摘要:
A compound selected from those of formula (I): wherein:
R 1 represents cycloalkyl, heterocycloalkyl, aryl or heteroaryl group, which are optionally substituted as defined in the description, R 2 represents alkyl, alkenyl, alkynyl, aryl or cycloalkyl group, R 3 represents cycloalkyl, heterocycloalkyl, aryl or heteroaryl group, which are optionally substituted by halogen, nitro, cyano, trifluoromethyl, oxo, alkyl, OR 6 , NR 6 R 7 , COR 6 , CO 2 R 6 , CONHOH, CONR 6 R 7 , -S(O) m R 6 , -S(O) m -NR 6 R 7 , -NR 6 COR 7 , -NR 6 SO 2 R 7 , -N(SO 2 R 7 ) 2 , -NR 6 -CO-NR 7 R 8 , and tetrazolyl, wherein m, R 6 , R 7 and R 8 , are as defined in the description, and optionally, its optical isomers , N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of phosphosdiesterase-7 (PDE7).
摘要翻译:选自式(I)的化合物:其中:R 1表示环烷基,杂环烷基,芳基或杂芳基,其如说明书中所定义,任选被取代,R 2表示烷基,烯基,炔基,芳基或环烷基, 硝基,氰基,三氟甲基,氧代,烷基,OR 6,NR 6 R 7,COR 6,CO 2 R 6,CONHOH,CONR 6 R 7,-S(O)m R 6,-S( O)m -NR 6 R 7,-NR 6 COR 7,-NR 6 SO 2 R 7,-N(SO 2 R 7)2,-NR 6 -CO-NR 7 R 8和四唑基,其中m,R 6,R 7和R 8如说明书中所定义, 异构体,N-氧化物及其与药学上可接受的酸或碱的加成盐,以及含有它们的药物可用作磷酸二酯酶-7(PDE7)的特异性抑制剂。
摘要:
The invention relates to 3- or 4-monosubstituted phenol derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-monosubstituted phenol derivatives are H 3 ligands and are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
摘要:
The invention relates to compounds of formula (I) wherein R 1 , R 2 and m are as defined in the description, their use as medicament, pharmaceutical compositions containing them and a process for their preparation. These compounds act as Phosphodiesterase inhibitors and inhibit in particular PDE-7.
摘要:
A compound selected from those of formula (I): wherein:
R 1a represents hydrogen, alkyl, or arylalkyl group, R 1b represents cycloalkyl, heterocycloalkyl, aryl or heteroaryl group, which are optionally substituted as defined in the description, R 2 represents alkyl, alkenyl, alkynyl, aryl or cycloalkyl group, R 3 represents cycloalkyl, heterocycloalkyl, aryl or heteroaryl group, which are optionally substituted by halogen, nitro, cyano, trifluoromethyl, oxo, alkyl, OR 6 , NR 6 R 7 , COR 6 , CO 2 R 6 , CONHOH, CONR 6 R 7 , -S(O) m R 6 , -S(O) m -NR 6 R 7 , -NR 6 COR 7 , -NR 6 SO 2 R 7 , -N(SO 2 R 7 ) 2 , -NR 6 -CO-NR 7 R 8 , and tetrazolyl, wherein m, R 6 , R 7 and R_, are as defined in the description, and optionally, its optical isomers , N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of phosphosdiesterase-7 (PDE-7).
摘要翻译:选自式(I)的化合物:其中:R 1a表示氢,烷基或芳基烷基,R 1b表示环烷基,杂环烷基,芳基或杂芳基,其如说明书中所定义任选被取代,R 2表示烷基 硝基,氰基,三氟甲基,氧代,烷基,OR 6,NR 6 R 7,COR 6,CO 2 R 6,CONHOH,CONR 6 R 7, -S(O)m R 6,-S(O)m -NR 6 R 7,-NR 6 COR 7,-NR 6 SO 2 R 7,-N(SO 2 R 7)2,-NR 6 -CO-NR 7 R 8和四唑基,其中m,R 6,R 7和R 8为 并且任选地,其光学异构体,N-氧化物及其与药学上可接受的酸或碱的加成盐,以及含有它们的药物可用作磷酸二酯酶-7(PDE-7)的特异性抑制剂。
摘要:
The invention provides compounds which are PDE7 inhibitors, having the following formula (I), (II) and (III), in which X 1 , X 2 , X 3 , X 4 , X, Y, Z, A and Z 1 are as defined in the description, methods for preparing them and their use for the treatment of disorders for which therapy by a PDE7 inhibitor is relevant.
摘要:
The invention provides compounds which are PDE7 inhibitors, having the following formula (I), (II) and (III), in which X 1 , X 2 , X 3 , X 4 , X, Y, Z, A and Z 1 are as defined in the description, methods for preparing them and their use for the treatment of disorders for which therapy by a PDE7 inhibitor is relevant.